A novel EIF3C-related CD8<sup>+</sup> T-cell signature in predicting prognosis and immunotherapy response of nasopharyngeal carcinoma.

Authors:
Li R; Wang Y; Wen X; Cheng B; Lv R and 8 more

Journal:
J Cancer Res Clin Oncol

Publication Year: 2024

DOI:
10.1007/s00432-023-05552-x

PMCID:
PMC10894114

PMID:
38400862

Journal Information

Full Title: J Cancer Res Clin Oncol

Abbreviation: J Cancer Res Clin Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability publicly available data were analyzed in this study. these data can be found here: tcga; gse102349"

Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors have no relevant financial or non-financial interests to disclose. Conflict of interest The authors have no relevant financial or non-financial interests to disclose."

Evidence found in paper:

"Funding This study was supported by the National Natural Science Foundation of China (Grant Numbers 81903134, 82172673, 82003214), the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University (Grant Number 2018J005), and Guangdong Basic and Applied Basic Research Foundation (Grant Number 2019A1515110076)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025